trial · primary record
[18F]florbetaben
Cardiac Amyloidosis
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 244 |
| Primary completion | 2026-05-05 |
| Primary endpoint | Sensitivity and specificity of the visual assessment of [18F]florbetaben PET images for the diagnosis of cardiac AL amyloidosis. |
| Registry ID | NCT05184088 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:09.819Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05184088
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.